The central dispute in the case is whether the Food and Drug Administration overlooked serious safety problems when it made mifepristone easier to obtain, including through mail-order pharmacies.
The FDA approved mifepristone in 2000 as a safe and effective way to end early pregnancies. There are rare occasions when mifepristone can cause dangerous, excessive bleeding that requires emergency care.
[
add
]
[
|
|
...
]